IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 61 filers reported holding IBERE PHARMACEUTICALS in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $131,604 | -5.3% | 13,200 | -5.8% | 0.03% | -18.9% |
| Q3 2022 | $139,000 | -82.0% | 14,020 | -82.2% | 0.04% | -73.0% |
| Q2 2022 | $774,000 | -2.5% | 78,930 | -2.6% | 0.14% | +10.5% |
| Q1 2022 | $794,000 | -11.2% | 81,060 | -9.1% | 0.12% | +15.9% |
| Q4 2021 | $894,000 | -1.9% | 89,180 | -2.1% | 0.11% | -18.3% |
| Q3 2021 | $911,000 | -3.0% | 91,100 | -2.5% | 0.13% | -15.5% |
| Q2 2021 | $939,000 | +1.8% | 93,470 | 0.0% | 0.16% | -20.9% |
| Q1 2021 | $922,000 | – | 93,470 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |